☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Aphaia Pharma
Aphaia Pharma Reports the P-II Study Results of APHD-012 Among Pre-Diabetic Individuals
June 21, 2024
Steffen-Sebastian Bolz, CSO of Aphaia Pharma Shares Insights from the P-II Study for Chronic Weight Management in Individuals with...
February 27, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.